Please, leave us your email and continue the registration process on Zoom
No upcoming webinars available
Sections
© 2025 Certest Pharma by Certest Biotec, S.L.
Trademarks contained herein are the property of Certest Pharma by Certest Biotec, and may be registered at Spain and/or other jurisdictions.
© COPYRIGHT CERTEST BIOTEC. TERMS AND CONDITIONS OF USE – COOKIES POLICY – PRIVACY POLICY
Certest Pharma develops targeted delivery strategies designed to improve the precision of RNA and oligonucleotide therapeutics while preserving formulation simplicity and manufacturability.
Our platform combines passive targeting, driven by propietary ionizable lipid selection and LNP composition, with active targeting approaches based on optimized ligand conjugation and advanced surface lipid technologies. This allows us to tailor biodistribution profiles and support more efficient interaction with selected tissues, receptors or cell populations.
For active targeting, Certest Pharma works with proprietary PEG alternative lipid technologies designed to improve ligand presentation on the LNP surface. This approach can make binding moieties more accessible to their target receptors while avoiding unnecessary complexity in LNP manufacturing.
Our targeting capabilities support ligand conjugated LNPs using peptides, antibodies or other binding moieties, enabling more precise development of next generation RNA and oligonucleotide therapeutics.
Our expertise extends to the pioneering field of RNA vaccines, where we partner with key industry leaders to bring life-saving innovations to those who need them most. Our seasoned professionals excel in guiding you through the entire development process of RNA vaccines, from initial design to small-scale production (non-cGMP). Leveraging our deep understanding of RNA technology, we ensure each vaccine is optimally designed for efficacy and accessibility. With Certest Pharma, you’re not just developing a vaccine; you’re shaping the future of personalized and responsive healthcare solutions.
Certest Pharma stands at the forefront of Oligotherapeutics, a field we’ve excelled in for years. Our deep understanding of oligonucleotides process and analysis guides our approach, ensuring we know precisely how most of them behave in therapeutic settings. Our focus is on optimization, bringing versatility to both small-scale and medium-scale processes. We assist in enhancing the delivery and stability of your oligonucleotide-based therapies. With our extensive experience, we are committed to advancing your therapy from concept to reality, ensuring efficacy and efficiency at every step.
We delve beyond mere delivery in RNA therapy, focusing on RNA sequence modifications to optimize your therapeutic outcomes. We engineer sophisticated alterations to RNA molecules, enhancing their stability, efficacy, and specificity. The extensive scientific knowledge of our expert teams and our cutting-edge resources, are dedicated to advancing this innovative field. We offer comprehensive support, from conceptualization to optimization, ensuring your RNA therapy reaches its full potential.
Certest Pharma specializes in developing LNP (Lipid Nanoparticle) compositions for RNA therapy delivery, emphasizing targeted delivery to specific cells. Our expertise guides the entire process, from concept to final product, ensuring the creation of the optimal LNP for each RNA therapy. Leveraging our extensive lipid library, we tailor LNPs for maximum efficacy, safety, and precise targeting. With our focus on innovative, targeted RNA delivery solutions, Certest Pharma is your ideal partner in pioneering RNA therapy advancements.
At Certest Pharma, we specialize in the cutting-edge field of ionizable lipids, key components in next-generation drug delivery. Ionizable lipids are unique molecules that help in the delivery of therapeutic agents, such as RNA or DNA, to specific target cells or organs. They are crucial in enhancing the stability and efficiency of treatments. Proudly, our expansive library, which is the result of testing over 1500 ionizable lipids, includes candidates that have been tailored for specific applications like targeted organ delivery or high protein expression. Our ongoing research continues to break new ground, consolidating Certest Pharma as an industry leader in ionizable lipid technology.
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
| Cookie | Duration | Description |
|---|---|---|
| cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
| cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
| cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
| cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
| cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
| viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
| Cookie | Duration | Description |
|---|---|---|
| _ga | 2 years | This cookie is installed by Google Analytics. The cookie is used to calculate visitor, session, campaign data and keep track of site usage for the site''s analytics report. The cookies store information anonymously and assign a randomly generated number to identify unique visitors. |
| _ga_2HCHMK2S3V | 2 years | It is used to limit the percentage of requests. If Google Analytics has been implemented through Google Tag Manager |
